Therapeutic Potential of Low-Dose IL-2 in Immune Thrombocytopenia: An Analysis of 3 Cases

Cytometry Part B - Clinical Cytometry - United States
doi 10.1002/cyto.b.21601
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

On the Therapeutic Scope of Low-Dose IL-2. Response To: ‘Circulating Regulatory T Cells Were Absolutelydecreased in Dermatomyositis/Polymyositispatients and Restored by Low-Dose IL-2’ by Zhang Et Al

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2019English

Immune Thrombocytopenia. Egyptian Experience With Study of Il-17, Tgfb, Cytokines in Chronic and Persistent Immune Thrombocytopenia Patients.

International Journal of Advanced Research
2018English

Increased Cytotoxic Potential of CD8+ T Cells in Immune Thrombocytopenia

British Journal of Haematology
Hematology
2019English

The IL-2/IL-2R System: From Basic Science to Therapeutic Applications to Enhance Immune Regulation

Immunologic Research
Immunology
2013English

Experience With Subcutaneous Immunoglobulin Therapy in Two Pediatric Cases of Immune Thrombocytopenia Purpura

Allergy, Asthma and Clinical Immunology
ImmunologyPulmonaryAllergyRespiratory Medicine
2012English

Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2

Current Diabetes Reports
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Immune Thrombocytopenia

Hospital Medicine Clinics
Medicine
2017English

Pulsed High-Dose Dexamethasone Modulates Th1-/Th2-Chemokine Imbalance in Immune Thrombocytopenia

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Potential Therapeutic Implications of IL-6/IL-6R/gp130-targeting Agents in Breast Cancer

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy